Top Page
CleanSpace Holdings Ltd.
(Sydney:CSX)
CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)
CleanSpace Holdings Ltd. Business Overview & Revenue Model
CleanSpace Holdings Ltd. Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.66M | 19.76M | 15.72M | 12.09M | 13.36M | 49.93M |
| Gross Profit | 9.47M | 14.78M | 11.36M | -5.16M | 9.75M | 40.27M |
| EBITDA | -1.07M | -824.55K | -3.49M | -10.55M | -14.10M | 17.15M |
| Net Income | 1.76M | -478.28K | -3.13M | -8.13M | -11.28M | 11.39M |
Balance Sheet | ||||||
| Total Assets | 26.92M | 27.57M | 26.05M | 28.98M | 38.36M | 50.72M |
| Cash, Cash Equivalents and Short-Term Investments | 9.83M | 10.47M | 9.76M | 12.16M | 24.30M | 38.24M |
| Total Debt | 2.89M | 4.54M | 3.45M | 4.00M | 4.13M | 4.38M |
| Total Liabilities | 5.62M | 8.41M | 6.95M | 7.02M | 8.60M | 9.99M |
| Stockholders Equity | 21.30M | 19.16M | 19.10M | 21.96M | 29.75M | 40.73M |
Cash Flow | ||||||
| Free Cash Flow | 1.78M | 1.01M | -1.76M | -11.97M | -13.60M | 11.73M |
| Operating Cash Flow | 1.95M | 1.11M | -1.73M | -11.96M | -13.00M | 13.46M |
| Investing Cash Flow | -1.17M | -778.38K | 2.00M | 7.06M | -628.00K | -14.18M |
| Financing Cash Flow | -461.86K | -559.87K | -637.10K | -211.49K | -357.95K | 16.19M |
CleanSpace Holdings Ltd. Technical Analysis
CleanSpace Holdings Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | AU$22.66M | -1.40 | -98.14% | ― | 14.84% | 39.64% | |
46 Neutral | AU$32.62M | -1.41 | -74.00% | ― | 23.31% | -17.35% | |
44 Neutral | AU$89.39M | -6.27 | -54.48% | ― | 34.20% | -23.90% | |
44 Neutral | AU$147.31M | -10.00 | -70.29% | ― | ― | -257.32% | |
43 Neutral | AU$37.11M | 7.24 | 8.71% | ― | 25.72% | 84.69% | |
41 Neutral | AU$47.20M | -2.66 | -180.06% | ― | -14.25% | -22.83% |
CleanSpace Holdings Ltd. Corporate Events
CleanSpace Holdings has disclosed changes to director Graham McLean’s indirect interests, reflecting increased equity exposure through both on-market share purchases and the conversion of restricted stock units. The transactions, conducted via Milray Enterprises Pty Ltd over several days in March 2026, lifted his holding to 628,992 shares, while a portion of his RSUs lapsed, signalling a rebalancing of his incentive-based remuneration structure.
The notice indicates McLean spent just over $31,000 acquiring additional shares on market and received an estimated $20,437 worth of shares from vested RSUs, while 75,000 RSUs expired unvested. The updated holding, which still includes 525,000 performance rights, underscores ongoing alignment between the director’s interests and shareholder outcomes, and provides investors with transparency on executive participation in the company’s equity.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.52 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings Ltd., traded on the ASX as CSX, is an Australian-listed company that complies with ASX regulatory requirements in administering its ordinary fully paid shares. The business is positioned within the domestic capital markets and periodically updates investors on changes to its quoted securities base.
The company has applied for quotation of 37,500 new ordinary fully paid shares on the ASX, following the issue of these securities on 9 March 2026. This incremental increase in quoted shares reflects the exercise or conversion of existing instruments and marginally expands CleanSpace Holdings’ free float and capital base for shareholders.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.52 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings has applied for quotation of 40,000 new fully paid ordinary shares on the Australian Securities Exchange, with an issue date of 26 March 2026. The modest share issuance, arising from the exercise or conversion of existing securities, represents a small capital and liquidity adjustment rather than a transformative change, signaling routine balance-sheet management for existing investors.
The application under Appendix 2A of the ASX Listing Rules indicates compliance with standard listing procedures and supports the tradability of these additional shares on market. While incremental, the move marginally expands the company’s free float and could enhance share liquidity, with minimal immediate impact on control or overall capital structure.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.59 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings has released its results presentation for the half year ended 31 December 2025, outlining its financial performance and operational developments for 1HFY26. The document emphasises that figures are prepared under IFRS, includes non-IFRS measures such as EBITDA and free cash flow to illustrate underlying performance, and notes that past performance should not be seen as guidance for future results.
The company stresses that the presentation is informational only, not an offer or financial product advice, and that it may contain forward-looking statements subject to uncertainty and change. CleanSpace also highlights that the material is current only as at the presentation date, may be updated without notice, and has been authorised for release by its board, reinforcing formal governance over its market communications.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.58 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace reported H1 FY26 revenue of $10.1 million, up 10% year on year, with gross margin improving to 75% and cash at bank rising 18% to $9.8 million, indicating sustained growth and strong unit economics. Operating EBITDA remained slightly negative at -$0.3 million but improved 23% versus the prior comparable period as the company balanced disciplined cost control with investment for future expansion.
Europe continued to be the main growth engine with sales up 26% to $6.7 million, driven by strong gains in Western Europe and the Nordics, while APAC and rest of world revenue fell 22% due to prior-year one-offs and slower Australian pipeline development. Management upgraded its FY26 outlook to target about 15% revenue growth, mid-70% gross margins, positive operating EBITDA in the second half and full-year positive cash flow, while committing to reinvest surplus cash to support international growth and market penetration.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.58 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings Limited reported a strong turnaround for the half-year to 31 December 2025, with revenue from ordinary activities rising 9.7% to $10.1 million and net profit after tax swinging to $1.84 million from a $0.40 million loss a year earlier. Net tangible assets per share improved to $0.27 from $0.24, while the company again refrained from declaring or paying any dividends in the period.
The headline profit growth of 554.5% was largely driven by a one-off gain from derecognising a loan owed to NSW Health Administration Corporation, after the liability was remeasured and written down to nil. Excluding this non-recurring accounting adjustment, underlying performance would have reflected a deeper loss, highlighting that the statutory result overstates the company’s operational improvement for stakeholders assessing its core earnings.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.58 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings Limited, an Australian manufacturer of premium respiratory protection solutions for industrial and healthcare markets, continues to invest in advanced powered air purifying respirator technology developed by a team of biomedical engineers. Its focus on differentiated design and approved products aims to enhance worker safety and health outcomes across demanding end markets.
The company has received an $891,000 cash rebate under the Australian federal government’s R&D Tax Incentive program for the financial year ended 30 June 2025, with funds earmarked for ongoing product research and development. The rebate reinforces CleanSpace’s position as an innovation-led player in the PAPR segment, supporting continued product advancement and potentially strengthening its competitive edge and value proposition for industrial customers and frontline workers.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.56 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings has applied to the ASX for quotation of 490,530 additional ordinary fully paid shares, with an issue date of 17 February 2026. The move modestly increases the company’s free float and equity base, signalling ongoing capital management activity that may enhance liquidity for existing shareholders and support future corporate initiatives.
The newly issued securities arise from the exercise or conversion of existing options or other convertible instruments into ordinary shares. This conversion-based issuance suggests prior commitments are being crystallised into equity, slightly diluting existing holdings while potentially aligning capital structure with long-term strategic or employee incentive arrangements.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.56 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings has reclassified a $2.8 million funding loan from the NSW Health Administration Corporation, awarded under the Medical Device Funding program in 2019, from a long-term liability to nil on its balance sheet as at 31 December 2025. The move follows the board’s assessment that the respirator project supported by the loan has not met commercial success milestones, with related sales contributing less than 0.5% of revenue in recent years and cumulative EBITDA remaining negative.
The accounting change, made under AASB 9 guidance and backed by external expert advice, will result in a $2.8 million uplift in ‘other gains’ in CleanSpace’s H1FY26 profit and loss statement. Management will reassess the likelihood of future commercial success and potential cash flows at each annual reporting date, with any renewed liability to be remeasured through the profit and loss, underscoring a more conservative stance on the project’s prospects while modestly improving near-term earnings.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.56 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings has notified the ASX that it has issued 863,000 unquoted restricted share awards under its employee incentive scheme. The new equity awards, which are not intended to be quoted on the exchange, represent a further use of stock-based compensation to reward and retain staff, modestly diluting existing shareholders while aligning employees’ interests more closely with the company’s long-term performance.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.70 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.
CleanSpace Holdings has scheduled the release of its half-year results for the period ended 31 December 2025 on 26 February 2026, with the chairman, CEO and CFO to brief investors and analysts via webcast and telephone. The planned briefing underscores the company’s ongoing communication with the market as it pursues growth in its specialised respiratory protection niche, with stakeholders likely to focus on how continued R&D investment and product differentiation are translating into financial performance and industry positioning.
The most recent analyst rating on (AU:CSX) stock is a Hold with a A$0.70 price target. To see the full list of analyst forecasts on CleanSpace Holdings Ltd. stock, see the AU:CSX Stock Forecast page.